Cargando…
Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055222/ https://www.ncbi.nlm.nih.gov/pubmed/32132522 http://dx.doi.org/10.1038/s41408-020-0286-5 |
_version_ | 1783503329315258368 |
---|---|
author | Richardson, Paul G. Corbacioglu, Selim |
author_facet | Richardson, Paul G. Corbacioglu, Selim |
author_sort | Richardson, Paul G. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7055222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70552222020-03-19 Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment Richardson, Paul G. Corbacioglu, Selim Blood Cancer J Correspondence Nature Publishing Group UK 2020-03-04 /pmc/articles/PMC7055222/ /pubmed/32132522 http://dx.doi.org/10.1038/s41408-020-0286-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Richardson, Paul G. Corbacioglu, Selim Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment |
title | Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment |
title_full | Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment |
title_fullStr | Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment |
title_full_unstemmed | Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment |
title_short | Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment |
title_sort | veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055222/ https://www.ncbi.nlm.nih.gov/pubmed/32132522 http://dx.doi.org/10.1038/s41408-020-0286-5 |
work_keys_str_mv | AT richardsonpaulg venoocclusivediseasesinusoidalobstructionsyndromeinpatientswithpriorgemtuzumabozogamicinliteratureanalysisofsurvivalafterdefibrotidetreatment AT corbaciogluselim venoocclusivediseasesinusoidalobstructionsyndromeinpatientswithpriorgemtuzumabozogamicinliteratureanalysisofsurvivalafterdefibrotidetreatment |